Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective Aspirin Dose in COPD
NCT05265299Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2023
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in chronic obstructive pulmonary disease (COPD), sponsored by Johns Hopkins University. Started May 2023; status: recruiting.
02
Drugs
aspirin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05265299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05265299.